Indisulam

Overview

Indisulam (E 7070) is a carbonic anhydrase inhibitor with anticancer activity. Indisulam (E 7070) is a sulfonamide agent that targets the G1 phase of the cell cycle. Indisulam (E 7070) causes a blockade in the G1/S transition through inhibition of the activation of both CDK2 and cyclin E . Indisulam (E 7070) targets splicing by inducing RBM39 degradation via recruitment to DCAF15 .

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Molecular Glues | Products > Signaling Pathways > Carbonic Anhydrase

Product Information

• Catalog No.: HY-13650
• CAS No.: 165668-41-7
• Molecular Formula: C14H12ClN3O4S2
• Molecular Weight: 385.85
• Purity: 99.80%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 2.17 mg/mL (5.62 mM); Clear solution
• Availability: In-stock

Source

Original product source